MUC16 and TP53 family co-regulate tumor-stromal heterogeneity in pancreatic adenocarcinoma

Overview of attention for article published in Frontiers in oncology, February 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 7 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 26,240 followers.

MUC16 and TP53 family co-regulate tumor-stromal heterogeneity in pancreatic adenocarcinoma. https://t.co/uarl0193Cu

24 Feb 2023

Reply Repost Favourite

MUC16 and TP53 family co-regulate tumor-stromal heterogeneity in pancreatic adenocarcinoma https://t.co/TZDzWgtmuB https://t.co/1E5TLtx3ip

05 Feb 2023

Reply Repost Favourite

New research: MUC16 and TP53 family co-regulate tumor-stromal heterogeneity in pancreatic adenocarcinoma: MUC16/CA125 is one of the few oldest cancer biomarkers still used in current clinical practice. As mesothelium is an abundant source of… https://t.co/

03 Feb 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.